Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

JENSCARE-B

10.400
-0.680-6.14%
Volume:465.20K
Turnover:4.89M
Market Cap:4.34B
PE:-21.89
High:11.300
Open:11.000
Low:10.250
Close:11.080
52wk High:11.580
52wk Low:2.420
Shares:417.17M
HK Float Shares:310.31M
Volume Ratio:1.23
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.475
ROE:-26.00%
ROA:-13.50%
PB:4.55
PE(LYR):-21.89
PS:295.21

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
JENSCARE-B
Exchange:
SEHK
Establishment Date:
2011
Employees:
174
Office Location:
Block 5, B Area,No. 777 Binhai 4th Road,Hangzhou Bay New Area,Ningbo,Zhejiang Province,China
Website:
http://www.jenscare.com
Zip Code:
- -
Phone:
86 574 6393 5666
Fax:
- -
Introduction:
Jenscare Scientific Co Ltd is a China-based company mainly engaged in the research and development of interventional products for the treatment of structural heart diseases and other related medical products. The Company develops a series of treatment solutions targeting different types of structural heart diseases, including tricuspid valve diseases, aortic valve diseases, mitral valve diseases, heart failure and cardiogenic stroke. The Company's products and pipelines mainly include LuX-Valve, LuX-Valve Plus, Ken-Valve, JensClip, JensRelive, MicroFlux and SimuLock. LuX-Valve is the first-generation transcatheter tricuspid valve replacement system designed to treat patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is the first-generation transcatheter aortic valve replacement system designed to treat patients with severe aortic regurgitation or combined with aortic stenosis.

Directors

Name
Position
LV Shi Wen
Chairman of the Board,Director,Chairman of the Strategic and Development Committee,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee
PAN Fei
Executive Director,Member of the Strategic and Development Committee
LIN Shou Kang
Independent Director,Member of the Strategic and Development Committee,Chairman of the Remuneration and Assessment Committee,Chairman of the Nomination Committee,Audit Committee Member
DU Ji Liu
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Chairman
MEI Le He
Independent Director,Audit Committee Member
TAN Ching
Director
ZHENG Jia Qi
Director
XIE You Pei
Director
CHEN Xin Xing
Director
XU Jing
Supervisor,Supervisory
TANG Hao
Supervisory
HU Bo
Supervisory

Shareholders

Name
Position
PAN Fei
CEO,CFO
LI Yi Bin
Vice General Manager
LI Yuan Yuan
CFO,Corporate Secretary
LV Shi Wen
CTO
HUANG Wei Chao
Corporate Secretary